Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5664614 | Transfusion and Apheresis Science | 2016 | 5 Pages |
Abstract
LTGAP appears to be a safe alternative to group AB plasma for emergency indications. By reviewing our percentage of group A plasma units that meet our low-titer cutoff and the current interest for the product, we can reduce the amount of units we titer each day by ~30% and can readjust that amount if there is increased interest. Besides lack of familiarity and limitations in computer software to incorporate LTGAP, the steady demand for AB plasma can potentially be attributed to trauma centers ordering more AB plasma than needed and potentially wasting it in nonurgent cases to avoid outdating the product and lack of institutional guidelines on when to switch from AB to type-specific plasma resulting in excess AB plasma being transfused.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Maksim Agaronov, Anthony DiBattista, Ellen Christenson, Richard Miller-Murphy, Donna Strauss, Beth H. Shaz,